Below you'll find a list of all posts that have been tagged as “CannMed”
We will be back with new episodes of the CannMed Coffee Talk Podcast next month! Please be patient as we recharge following the CannMed 24 Innovation and Investment Summit, and prepare for next year’s event! Be sure to sign up for email alerts at CannMedEvents.com so you will receive notifications when we publish the CannMed 24 oral presentation videos and announce details …
The CannMed Coffee Talk Podcast is taking the month of December off. We will be back with new episodes starting January 4th. We are taking this break so that we can focus on processing our CannMed 23 abstract submissions and laying out the program for the summit in May. We received a lot of great submissions, and we expect the …
Dr. Ziva Cooper is the Director of the UCLA Center for Cannabis and Cannabinoids. She is also an Associate Professor in the Department of Psychiatry and Biobehavioral Sciences and Department of Anesthesiology at the David Geffen School of Medicine. Her current research involves understanding variables that influence both the therapeutic potential and adverse effects of cannabis and cannabinoids through double-blind, …
For decades, the cannabis industry has struggled to erase a deep-rooted stigma, punctuated by various anti-cannabis propaganda campaigns, most notably by films, such as Reefer Madness. The complex science, innovative research, and health benefits of this plant are often over-shadowed by false narratives driven by fear, politics, and competing industry profits. It’s time for that narrative to change. We are …
We had a chance to catch up with Meredith Burak, Director of Global Relations for Asana Bio Group, who will lead a Women’s Health panel at CannMed 2018, comprised of experts who are advancing science and products to benefit women’s health. In the video below, Burak shares some of the information she has found while studying how cannabis can help …
Our latest CannMed 2018 speaker interview is with Rob Viglione from Horizen who will be speaking as part of our Cryptocurrency Track at CannMed 2018. Cryptocurrencies and blockchains can radically disrupt many aspects of the cannabis market. Cryptocurrencies are now funding cannabis research projects, Cannabis scientific conferences, and ICO financing. The CannMed Crypto track will touch on ICO financing in the cannabis space, cryptocurrencies …
We had a chance to speak with Dr. Michael Dor, Chief Medical Consultant in the Israeli Health Ministry Medical Cannabis Unit, about the challenges he has faced implementing the country’s medical cannabis program. In the video below, Dr. Dor says physicians in Israel are resistant to prescribing cannabis, but it’s not because there is not enough medical evidence. It’s just …
We are so fortunate to have Dr. Raphael Mechoulam on our CannMed 2018 Advisory Board. His early contributions to cannabis research are the foundation that today’s cannabis researchers and healthcare providers use to advance the understanding this amazing plant’s medical efficacy. We had the chance to speak with Dr. Mechoulam at his laboratory in Israel about his pioneering cannabis research …
For far too long, opioid-based painkillers have been the go-to treatment for chronic pain of varying types. This practice has helped lay the foundation for the opioid crisis that ravages our nation today. By now, you’ve likely heard the statistics, but they’re worth repeating. Of the approximately 20 million Americans struggling with a substance abuse disorder, nearly 2 million were …
Medicinal cannabis is by no means a new concept. The truth is, humans have been using cannabis as a treatment for a variety of ailments for thousands of years. According to Chinese legend, cannabis was used as early as 2700 B.C. as a treatment for a variety ailments including gout, rheumatism, and even malaria. However, using cannabis to treat cancer …
